Obinutuzumab

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T9924-1mg	1 mg		-		7 - 10 business days*		241.00€
TGM-T9924-5mg	5 mg		-		7 - 10 business days*		724.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20... more

Close menu

Product information "Obinutuzumab"

Description: Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. Target: Others. References: Herter S, et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol Cancer Ther. 2013 Oct,12(10):2031-42.

Keywords:	Obinutuzumab/afutuzumab
Supplier:	TargetMol
Supplier-Nr:	T9924

Properties

Conjugate:	No
MW:	150 kD

Database Information

KEGG ID :	K06466 \| Matching products
UniProt ID :	P11836 \| Matching products
Gene ID :	GeneID 931 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Obinutuzumab"

Write a review